Marshall Wace North America’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-220
| Closed | -$54K | – | 1696 |
|
|
2019
Q4 | $54K | Sell |
220
-646
| -75% | -$159K | ﹤0.01% | 1147 |
|
|
2019
Q3 | $299K | Buy |
866
+295
| +52% | +$102K | ﹤0.01% | 891 |
|
|
2019
Q2 | $526K | Buy |
571
+456
| +397% | +$420K | ﹤0.01% | 881 |
|
|
2019
Q1 | $183K | Buy |
+115
| New | +$183K | ﹤0.01% | 1003 |
|
|
2017
Q4 | – | Sell |
-627
| Closed | -$1.81M | – | 1674 |
|
|
2017
Q3 | $1.81M | Buy |
627
+97
| +18% | +$279K | 0.01% | 819 |
|
|
2017
Q2 | $1.27M | Buy |
+530
| New | +$1.27M | 0.01% | 860 |
|
|
2013
Q4 | $1.6M | Sell |
456
-588
| -56% | -$2.06M | 0.03% | 317 |
|
|
2013
Q3 | $4.29M | Buy |
+1,044
| New | +$4.29M | 0.13% | 182 |
|